Actavis UK raised drug prices 12,000 pct, watchdog finds

Actavis UK raised drug prices 12,000 pct, watchdog finds


Dec 16 Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12,000 percent, Britain's competition watchdog said in a provisional ruling on Friday. Higher prices meant the tablets cost Britain's National Health Service about 70 million pounds last year, up from about 522,000 pounds previously, the CMA said.



from Biotech News